Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.
about
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolismLinkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.Septins promote stress fiber-mediated maturation of focal adhesions and renal epithelial motility.Modulation of mouse macrophage proteome induced by Toxoplasma gondii tachyzoites in vivo.Septin functions in organ system physiology and pathology.Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers.Comparative mitochondrial proteomics: perspective in human diseases.Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism.Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancerPre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma.Energy matters: mitochondrial proteomics for biomedicine.Septin roles in tumorigenesis.The proteomic landscape of renal tumors.Loss of regulators of vacuolar ATPase function and ceramide synthesis results in multidrug sensitivity in Schizosaccharomyces pombe.Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometryVHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
P2860
Q30316025-8A16699F-5DA2-4B51-8DAC-F55FB7EB903EQ30316645-17EC99FE-537F-4452-AA52-180BE5A266A6Q30318519-CF64E7C5-077B-4D02-9ABB-EABCC7C3EC8EQ30319002-3C179C1D-7047-4A2B-9A89-E22E74A55E6DQ30405644-C66D19BF-AED5-44B6-B550-638D9E806F01Q33902501-E789098D-DF02-470D-9E7E-E4B86D2DB169Q35673813-7F8640FE-4C64-4337-99F9-E49CC5B29BB2Q35845396-4D986C22-4B82-4985-9CCF-1E4EC088EF29Q35914386-C981D2E0-C36A-4842-8FB3-2056651BF145Q36260036-8F8F68B2-7A87-4852-B1F7-CA6477A60C31Q37002164-5D8D61B2-E711-4411-B527-3E9EE2E2AADCQ37296108-0981DCC7-A282-4D63-8691-E8F9310358FFQ37400502-7331BCE5-187D-44CC-84EC-34BEA2AA42B0Q37829412-1480492F-C1E6-44E2-99EC-A029EC244CE8Q37899208-C159A696-65D1-43BD-8C2D-25175EDEF747Q38803559-3EE17758-1DF3-4B87-9576-795A0AD03DF8Q39755998-08E04205-6284-42C8-AC0E-9A614836DA8CQ42367910-4A0857E8-22FC-427B-970D-FC30867DA1A6Q58584059-F1D21935-4004-4065-B004-443F792FE47E
P2860
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en-gb
type
label
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en-gb
prefLabel
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en-gb
P2093
P2860
P50
P356
P1433
P1476
Proteomic identification of a ...... tin 2 in renal cell carcinoma.
@en
P2093
Anthea J Stanley
Nick Totty
Patricia Harnden
Rachel A Craven
Sarah Hanrahan
William S Trimble
P2860
P304
P356
10.1002/PMIC.200500811
P577
2006-07-01T00:00:00Z